Cite
HARVARD Citation
Tongu, M. et al. (n.d.). Intermittent chemotherapy can retain the therapeutic potential of anti‐CD137 antibody during the late tumor‐bearing state. Cancer science. 106 (1), pp. 9-17. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tongu, M. et al. (n.d.). Intermittent chemotherapy can retain the therapeutic potential of anti‐CD137 antibody during the late tumor‐bearing state. Cancer science. 106 (1), pp. 9-17. [Online].